A healthcare executive recently took to LinkedIn to celebrate what he described as a bold strategy: actively “poaching” high-performing surgeons from competitors. His CFO questioned his sanity. His COO wondered whether he’d lost his mind. But the executive had done the math. A “star” surgeon performing 45 cases per month at an average facility fee of $5,200 would generate $2.8 million in annual revenue, with a 38% margin—more than $1 million in annual margin contribution. A $570,000 signing investment would yield a 186% return on margin in year one. By year five? Nearly $6 million in margin from a single recruit.

The executive’s motto? “Talent wins. Every. Single. Time.”

The comments to his post were largely celebratory. Surgeons deserve to be paid their worth. Transparency is refreshing. Offer equity. Add retention bonuses. Align incentives. Others pointed out the “halo effect”—that elite surgeons attract referrals, elevate peers, and signal market dominance.

But amid the applause, a few dissenting voices asked a more piercing question:

Why are we applauding companies for proudly making money off “talent”?

And more pointedly: Are surgeons being valued as professionals—or monetized as margin-generating assets, no different than widgets?

The executive’s post was striking not because of the numbers. Health care is expensive. Ambulatory surgery centers are businesses. Leaders must think in financial terms. That is reality.

What was striking was what was missing.

There was no mention of patient outcomes. No mention of mentorship. No reference to culture, ethics, professionalism, compassion, or character. The “star” designation rested entirely on productivity and margin contribution. Talent, in this telling, was synonymous with throughput.

In medicine, that is an impoverished definition.

Contrast this with the story of Carl Henderson, the late owner of Carl’s Cards & Collectibles in Havertown, Pennsylvania, a Philadelphia suburb where I was raised. For 31 years, Henderson ran his shop with warmth and integrity, navigating what can be a transactional memorabilia world with generosity and heart. He cared about the 10-year-old with a few dollars in his pocket as much as the collector purchasing a limited-edition signed bat. “It wasn’t always about the dollar,” his daughter told The Philadelphia Inquirer. He knew his clientele. He donated to charity. He created a space where children going through family turmoil found stability and welcome.

Henderson’s shop survived not because he optimized margins, but because he embodied character.

Now, of course, a surgeon and a shopkeeper are not the same. One operates on human bodies; the other sells sports memorabilia. One holds lives in their hands; the other holds baseball cards.

Or are they so different?

In both cases, the enterprise rests on character. Customers return not simply because of inventory, but because of how they are treated. Patients choose surgeons not solely for technical skill, but for judgment, empathy, humility, and steadiness under pressure.

Character is not ornamental in medicine. It is foundational.

The executive’s spreadsheet cannot quantify the surgeon who pauses to sit with a frightened family. It cannot capture the colleague who mentors younger physicians without calculating RVUs. It cannot measure the surgeon who declines to operate when the operation is unnecessary — thereby reducing revenue but preserving integrity.

Yet those qualities define excellence in medicine.

Healthcare has long wrestled with the tension between professionalism and commercialization. When facility fees, margin percentages, and return on investment dominate the language of leadership, the risk is not merely aesthetic. It is moral drift.

If surgeons are framed primarily as million-dollar margin engines, they will eventually see themselves—and be seen by others—as such. That framing alters behavior. It shapes incentives. It subtly communicates that what matters most is volume and profitability.

And once that happens, the profession thins.

We have seen this movie before. When downstream revenue is attributed to “the system” but compensation is attributed to “the surgeon,” executives sometimes declare service lines unprofitable—until they close them and watch revenue evaporate. The math was incomplete because it excluded relational capital. It excluded trust. It excluded reputation. It excluded character.

The LinkedIn post celebrated the “halo effect.” But halos are not financial instruments. They are moral symbols.

What actually creates a halo? Technical skill alone does not. A surgeon may be fast, prolific, and profitable—yet toxic to team culture. Another may be slightly less productive but a master educator, a unifier, a stabilizing presence in crises.

Which surgeon builds a sustainable organization?

Healthcare leaders are not wrong to consider margin. In fact, ignoring economics is naïve. Surgery centers must remain solvent. Staff must be paid. Technology must be purchased. Patients benefit when organizations are stable.

But financial acumen is not a substitute for moral imagination.

Imagine if the executive had written:

“I’m investing in surgeons who are not only technically outstanding, but who elevate our culture, mentor our teams, and deliver exceptional outcomes. The numbers matter—but they follow from excellence, the soft skills as well as the hard ones.”

Imagine if he had described the qualities he sought beyond case volume: judgment, humility, compassion, resilience, collaboration.

Imagine if he had framed the $570,000 not merely as a bet on margin, but as a commitment to professional excellence and patient trust.

That post would have still acknowledged economic reality. It would have still made sense to a CFO. But it would have reminded the rest of us that medicine is not a hedge fund.

Carl Henderson left a corporate steel job in 1995 to open a card shop because he loved collecting and wanted something different. His family thought he was out of his mind. For three decades, he built not just a business, but a community. When he died unexpectedly, flowers filled the doorway, 400 people attended his memorial, and former professional athletes showed up to pay respects.

That is return on investment of a different kind.

Medicine does not need fewer financially savvy leaders. It needs leaders who can hold two truths at once:

Yes, margins matter.

And no, margins are not the measure of a person.

A “star” surgeon is not defined solely by cases per month. A true star shines because others feel illuminated in their presence—patients, trainees, nurses, anesthesiologists, colleagues.

Healthcare executives may win talent wars by writing large checks. But they will only build enduring institutions by cultivating character.

Talent may win. But character sustains.

Every. Single. Time.

Arthur Lazarus is a former Doximity Fellow, a member of the editorial board of the American Association for Physician Leadership, and an adjunct professor of psychiatry at the Lewis Katz School of Medicine at Temple University in Philadelphia. He is the author of several books on narrative medicine and the fictional series Real Medicine, Unreal Stories. His latest book is Still Life with Stethoscope and Typewriter: Essays and Echoes of Narrative Medicine.